UA40578C2 - Сульфоніламінопіримідини і фармацевтичний препарат на їх основі - Google Patents
Сульфоніламінопіримідини і фармацевтичний препарат на їх основіInfo
- Publication number
- UA40578C2 UA40578C2 UA94005281A UA94005281A UA40578C2 UA 40578 C2 UA40578 C2 UA 40578C2 UA 94005281 A UA94005281 A UA 94005281A UA 94005281 A UA94005281 A UA 94005281A UA 40578 C2 UA40578 C2 UA 40578C2
- Authority
- UA
- Ukraine
- Prior art keywords
- sulfonylaminopyrimidines
- compounds
- formula
- diseases
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Цей винахід належить до нових сульфоніламінопіримідинів і їх застосування як лікарських препаратів. Сполуки наведеної формули є інгібіторами ендотеліальних рецепторів. Тому вони можуть використовуватись для лікування захворювань, пов’язаних з активністю ендотелія, насамперед серцевосудинних захворювань, як гіпертонія, ішемія, спазми судин і стенокардія. Винахід стосується застосування сполук формули I і їх солей для лікування вищенаведених захворювань, їх застосування як біологічно активних речовин для одержання лікарських засобів, призначених для зазначених цілей, а також фармацевтичних препаратів, що містять сполуки формули I або їх солі.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH192493 | 1993-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA40578C2 true UA40578C2 (uk) | 2001-08-15 |
Family
ID=4221780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA94005281A UA40578C2 (uk) | 1993-06-28 | 1994-06-27 | Сульфоніламінопіримідини і фармацевтичний препарат на їх основі |
Country Status (41)
Country | Link |
---|---|
US (1) | US5541186A (uk) |
EP (1) | EP0633259B1 (uk) |
JP (1) | JP2545200B2 (uk) |
KR (1) | KR100338905B1 (uk) |
CN (1) | CN1050839C (uk) |
AT (1) | ATE175669T1 (uk) |
AU (1) | AU678467B2 (uk) |
BG (1) | BG61691B1 (uk) |
BR (2) | BR9402558A (uk) |
CA (1) | CA2125730C (uk) |
CO (1) | CO4230230A1 (uk) |
CZ (1) | CZ287184B6 (uk) |
DE (1) | DE59407626D1 (uk) |
DK (1) | DK0633259T3 (uk) |
EC (1) | ECSP941111A (uk) |
ES (1) | ES2127850T3 (uk) |
FI (1) | FI112944B (uk) |
GR (1) | GR3029874T3 (uk) |
HR (1) | HRP940370B1 (uk) |
HU (2) | HUT67636A (uk) |
IL (1) | IL110089A (uk) |
IS (1) | IS4185A (uk) |
LT (1) | LT3723B (uk) |
LV (1) | LV11175B (uk) |
MY (1) | MY110871A (uk) |
NO (1) | NO306403B1 (uk) |
NZ (1) | NZ260842A (uk) |
PE (1) | PE56794A1 (uk) |
PH (1) | PH30688A (uk) |
PL (2) | PL177031B1 (uk) |
RO (1) | RO114325B1 (uk) |
RU (1) | RU2142457C1 (uk) |
SG (1) | SG43888A1 (uk) |
SI (1) | SI0633259T1 (uk) |
SK (1) | SK280736B6 (uk) |
SV (1) | SV1994000028A (uk) |
TW (1) | TW394761B (uk) |
UA (1) | UA40578C2 (uk) |
UY (1) | UY23797A1 (uk) |
YU (1) | YU40794A (uk) |
ZA (1) | ZA944434B (uk) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514696A (en) * | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
US6743783B1 (en) * | 1993-12-01 | 2004-06-01 | Marine Polymer Technologies, Inc. | Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine |
US6063911A (en) * | 1993-12-01 | 2000-05-16 | Marine Polymer Technologies, Inc. | Methods and compositions for treatment of cell proliferative disorders |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US6268369B1 (en) | 1994-11-16 | 2001-07-31 | Synaptic Pharmaceutical Corporation | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
MX9703518A (es) | 1994-11-16 | 1997-08-30 | Synaptic Pharma Corp | Dihidropirimidinas y usos de las mismas. |
CA2162630C (en) * | 1994-11-25 | 2007-05-01 | Volker Breu | Sulfonamides |
TW313568B (uk) * | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
ES2196090T3 (es) | 1994-12-28 | 2003-12-16 | Kowa Co | Derivados pirimidinicos. |
US5780473A (en) * | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5760038A (en) * | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5573762A (en) * | 1995-04-24 | 1996-11-12 | Genentech, Inc. | Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy |
US5739333A (en) * | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
ES2210384T3 (es) * | 1995-09-06 | 2004-07-01 | Kowa Co. Ltd. | Derivados de la pirimidina. |
JPH09124620A (ja) | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
CZ260596A3 (en) * | 1995-10-12 | 1997-12-17 | Hoffmann La Roche | Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof |
US6228861B1 (en) | 1995-11-16 | 2001-05-08 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
WO1997022595A1 (fr) * | 1995-12-20 | 1997-06-26 | Yamanouchi Pharmaceutical Co., Ltd. | Derives arylethenesulfonamide et composition de medicaments renfermant ces derives |
SG87051A1 (en) | 1996-02-20 | 2002-03-19 | Bristol Myers Squibb Co | Process for preparing biphenyl isoxazole sulfonamide intermediates |
US5856507A (en) * | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
US5939446A (en) * | 1996-04-09 | 1999-08-17 | Bristol-Myers Squibb Co. | Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists |
US6172066B1 (en) | 1996-05-16 | 2001-01-09 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US6245773B1 (en) | 1996-05-16 | 2001-06-12 | Synaptic Pharmaceutical Corporation | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
US5985830A (en) * | 1996-09-16 | 1999-11-16 | Dalhousie University | Use of IGF-I for the treatment of kidney disorders |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
WO1998033781A1 (en) * | 1997-01-30 | 1998-08-06 | Bristol-Myers Squibb Company | Method for preventing or treating low renin hypertension by administering an endothelin antagonist |
US6274585B1 (en) | 1998-12-23 | 2001-08-14 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US6680323B2 (en) | 1998-12-23 | 2004-01-20 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
CA2315614C (en) * | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
WO2001081338A1 (en) * | 2000-04-25 | 2001-11-01 | Actelion Pharmaceuticals Ltd | Substituted sulfonylaminopyrimidines |
US6720324B2 (en) * | 2000-07-05 | 2004-04-13 | Synaptic Pharmaceutical Corporation | Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
MY140724A (en) | 2000-07-21 | 2010-01-15 | Actelion Pharmaceuticals Ltd | Novel arylethene-sulfonamides |
US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
US7091201B2 (en) | 2000-09-25 | 2006-08-15 | Actelion Pharmaceuticals Ltd. | Arylalkane-sulfonamides having endothelin-antagonist activity |
US6639082B2 (en) | 2000-10-17 | 2003-10-28 | Bristol-Myers Squibb Company | Methods for the preparation of biphenyl isoxazole sulfonamides |
KR100374326B1 (ko) * | 2000-11-29 | 2003-03-03 | 한국과학기술연구원 | 6-히드록시-1, 3-디옥신-4-온 고리를 가진인간면역결핍바이러스 프로테아제 억제 화합물 및 그의제조방법 |
HU229403B1 (en) | 2000-12-18 | 2013-12-30 | Actelion Pharmaceuticals Ltd | Novel sulfamides and their use as endothelin receptor antagonists |
WO2002083650A1 (en) * | 2001-04-11 | 2002-10-24 | Actelion Pharmaceuticals Ltd | Novel sulfonylamino-pyrimidines |
EP1507756B1 (en) | 2002-05-24 | 2015-07-22 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
AU2011218661B2 (en) * | 2002-05-24 | 2012-07-05 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
US7227035B2 (en) * | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
JP4611746B2 (ja) * | 2002-11-18 | 2011-01-12 | ケモセントリックス, インコーポレイテッド | アリールスルホンアミド |
US7741519B2 (en) * | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
WO2004050640A1 (en) | 2002-12-02 | 2004-06-17 | Actelion Pharmaceuticals Ltd | Pyrimidine-sulfamides and their use as endothelian receptor antagonist |
DE102004027119A1 (de) | 2003-06-06 | 2004-12-30 | Schott Ag | UV-Strahlung absorbierendes Glas mit geringer Absorption im sichtbaren Bereich, ein Verfahren zu seiner Herstellung sowie dessen Verwendung |
PT1725540E (pt) | 2004-03-05 | 2012-11-29 | Hoffmann La Roche | Diaminopirimidinas como antagonistas de p2x3 e p2x2/3 |
US7745436B2 (en) * | 2004-04-13 | 2010-06-29 | Synta Pharmaceuticals Corporation | Disalt inhibitors of IL-12 production |
WO2006000371A2 (en) | 2004-06-28 | 2006-01-05 | F.Hoffmann-La Roche Ag | Pyrimidine derivatives as 11beta-hsd1 inhibitors |
KR100847203B1 (ko) * | 2004-06-28 | 2008-07-17 | 에프. 호프만-라 로슈 아게 | 피리미딘 유도체 |
TW200628467A (en) | 2004-11-11 | 2006-08-16 | Actelion Pharmaceuticals Ltd | Novel sulfamides |
EP1924565B1 (en) * | 2005-09-01 | 2016-09-14 | F.Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p3x2/3 modulators |
JP4850911B2 (ja) * | 2005-09-01 | 2012-01-11 | エフ.ホフマン−ラ ロシュ アーゲー | P2x3およびp2x2/3モジュレーターとしてのジアミノピリミジン |
CA2620129C (en) | 2005-09-01 | 2014-12-23 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
JP2009530284A (ja) * | 2006-03-13 | 2009-08-27 | エンサイシブ・ファーマシューティカルズ・インコーポレイテッド | 拡張期心不全を治療するための方法と組成物 |
JP2009530280A (ja) * | 2006-03-13 | 2009-08-27 | エンサイシブ・ファーマシューティカルズ・インコーポレイテッド | シタクスセンタンナトリウムの配合物 |
US20080026061A1 (en) * | 2006-06-22 | 2008-01-31 | Reichwein John F | Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide |
AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
NZ616957A (en) | 2007-02-19 | 2015-06-26 | Marinepolymer Tech Inc | Hemostatic compositions and therapeutic regimens |
MX2010001837A (es) | 2007-08-17 | 2010-03-10 | Actelion Pharmaceuticals Ltd | Derivados de 4-pirimidinasulfamida. |
AU2011239466B2 (en) | 2010-04-15 | 2015-01-22 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly -N-acetylglucosamine nanofibers |
NZ732118A (en) | 2011-04-15 | 2018-11-30 | Marine Polymer Tech Inc | Treatment of disease with poly-n-acetylglucosamine nanofibers |
RU2604060C1 (ru) * | 2015-10-06 | 2016-12-10 | федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) | Способ получения 2,5-дизамещенных 6-гидроксипиримидин-4(3н)-онов |
SG11201808220VA (en) | 2016-03-22 | 2018-10-30 | Merck Sharp & Dohme | Allosteric modulators of nicotinic acetylcholine receptors |
RU2643356C2 (ru) * | 2016-06-22 | 2018-02-01 | федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Новое n-арилсульфамидное производное о-бензоиламинобензойной кислоты, обладающее анксиолитической, актопротекторной и антидепрессивной активностью |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0210526B1 (de) | 1985-07-24 | 1989-05-24 | Siemens Aktiengesellschaft | Kernreaktorbrennelement |
TW270116B (uk) | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
RU2086544C1 (ru) | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
TW287160B (uk) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche |
-
1994
- 1994-06-08 TW TW083105221A patent/TW394761B/zh not_active IP Right Cessation
- 1994-06-13 CA CA002125730A patent/CA2125730C/en not_active Expired - Fee Related
- 1994-06-16 EP EP94109257A patent/EP0633259B1/de not_active Expired - Lifetime
- 1994-06-16 SI SI9430236T patent/SI0633259T1/xx unknown
- 1994-06-16 SG SG1996004116A patent/SG43888A1/en unknown
- 1994-06-16 AT AT94109257T patent/ATE175669T1/de active
- 1994-06-16 DE DE59407626T patent/DE59407626D1/de not_active Expired - Lifetime
- 1994-06-16 DK DK94109257T patent/DK0633259T3/da active
- 1994-06-16 ES ES94109257T patent/ES2127850T3/es not_active Expired - Lifetime
- 1994-06-21 ZA ZA944434A patent/ZA944434B/xx unknown
- 1994-06-22 IL IL11008994A patent/IL110089A/xx not_active IP Right Cessation
- 1994-06-24 HU HU9401907A patent/HUT67636A/hu unknown
- 1994-06-24 HR HR01924/93-6A patent/HRP940370B1/xx not_active IP Right Cessation
- 1994-06-24 AU AU65948/94A patent/AU678467B2/en not_active Ceased
- 1994-06-24 NZ NZ260842A patent/NZ260842A/en unknown
- 1994-06-24 IS IS4185A patent/IS4185A/is unknown
- 1994-06-27 LV LVP-94-131A patent/LV11175B/lv unknown
- 1994-06-27 PL PL94323036A patent/PL177031B1/pl unknown
- 1994-06-27 PE PE1994245279A patent/PE56794A1/es not_active Application Discontinuation
- 1994-06-27 US US08/266,072 patent/US5541186A/en not_active Expired - Lifetime
- 1994-06-27 EC EC1994001111A patent/ECSP941111A/es unknown
- 1994-06-27 RU RU94022258/04A patent/RU2142457C1/ru not_active IP Right Cessation
- 1994-06-27 MY MYPI94001661A patent/MY110871A/en unknown
- 1994-06-27 PL PL94304007A patent/PL175771B1/pl unknown
- 1994-06-27 KR KR1019940014774A patent/KR100338905B1/ko not_active IP Right Cessation
- 1994-06-27 YU YU40794A patent/YU40794A/sh unknown
- 1994-06-27 NO NO942428A patent/NO306403B1/no unknown
- 1994-06-27 UA UA94005281A patent/UA40578C2/uk unknown
- 1994-06-27 BG BG98880A patent/BG61691B1/bg unknown
- 1994-06-27 FI FI943084A patent/FI112944B/fi not_active IP Right Cessation
- 1994-06-27 BR BR9402558A patent/BR9402558A/pt not_active Application Discontinuation
- 1994-06-27 PH PH48525A patent/PH30688A/en unknown
- 1994-06-27 CZ CZ19941573A patent/CZ287184B6/cs not_active IP Right Cessation
- 1994-06-27 CO CO94027814A patent/CO4230230A1/es unknown
- 1994-06-27 UY UY23797A patent/UY23797A1/es not_active IP Right Cessation
- 1994-06-27 LT LTIP1979A patent/LT3723B/lt not_active IP Right Cessation
- 1994-06-27 CN CN94106574A patent/CN1050839C/zh not_active Expired - Fee Related
- 1994-06-28 SK SK779-94A patent/SK280736B6/sk unknown
- 1994-06-28 RO RO94-01112A patent/RO114325B1/ro unknown
- 1994-06-28 SV SV1994B00028A patent/SV1994000028A/es not_active Application Discontinuation
- 1994-06-28 JP JP6146003A patent/JP2545200B2/ja not_active Expired - Fee Related
-
1995
- 1995-06-21 HU HU95P/P00298P patent/HU211533A9/hu unknown
-
1996
- 1996-12-05 BR BR1100089-9A patent/BR1100089A/pt active IP Right Grant
-
1999
- 1999-04-05 GR GR990400963T patent/GR3029874T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA40578C2 (uk) | Сульфоніламінопіримідини і фармацевтичний препарат на їх основі | |
EA199800943A1 (ru) | Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы | |
TR200103178T2 (tr) | İntegrinlerin reseptörlere bağlanmasını engelleyen karboksilik asit türevleri. | |
ES2145913T3 (es) | Inhibidores de metaloproteasas. | |
MX9801716A (es) | Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina. | |
ATE556705T1 (de) | Darreichungsform enthaltend taxol in kristalliner form | |
MY120064A (en) | Indole derivatives as inhibitors or factor xa | |
ATE278397T1 (de) | Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose | |
ATE264692T1 (de) | Verwendung von no synthase hemmern und fängern von reaktiven sauerstoffsformen zur behandlung von ischämie | |
IL146312A (en) | 3-(2-oxo-pyridinyl)-acylamino-propanoic acid derivatives that inhibit the binding of integrins to their receptors and pharmaceutical compositions comprising the same | |
GR3035014T3 (en) | N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
EP1019047A4 (en) | ANTITHROMBOTIC AGENTS | |
AU5879798A (en) | Agents inhibiting progress of pterygium and postoperative recurrence of the same | |
EP1027051A4 (en) | ANTITHROMBOTIC AGENTS | |
BR9810314A (pt) | Derivados de 5-substituìdo-1,2,4-tiadiazolila que inibem de angiogênese | |
DE59406568D1 (de) | Cephalostatin-analoga und ihre verwendung als antitumormittel | |
RU97122020A (ru) | Производные 1,2,5-оксадиазоло[3,4-d]пиридазин-5,6-диоксида в качестве активаторов растворимой формы гуанилатциклазы и средств для лечения заболеваний сердечно-сосудистой системы и фармацевтические композиции на их основе | |
DE69824410D1 (en) | Antithrombosemittel | |
TH51071A3 (th) | ตัวยับยั้งเอนไซม์ย่อยสลายโปรตีน | |
ITMI921151A1 (it) | Composti terapeuticamente attivi, particolarmente ad attivita' nootropica e procedimento per la loro preparazione | |
TH42376A (th) | ซัลโฟนามีด ที่มีพันธะที่-n ของเฮเทอโรไซคลิค ไธโอเอสเทอร์ | |
TW200517112A (en) | Compounds and pharmaceutical composition for inhibiting HIV protease | |
NO932982L (no) | Stabile salter av (+)-(1s,2r)-2-((n-(2-hydroksylamino-2-oksoetyl)-n-metylamino)karbonyl)cykloheksan-1-karboksylsyreog fremgangsmaate for fremstilling derav og farmasoeytiske sammensetninger som inneholder disse |